<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Godara ML</submitter><funding>U.S. Department of Energy</funding><funding>National Institutes of Health</funding><funding>NIH HHS</funding><pagination>34991</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12504599</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>15(1)</volume><pubmed_abstract>Theranostics, a combined approach of diagnostics and therapeutics, often employs F-block therapeutic radionuclides including &lt;sup>225&lt;/sup>Ac, &lt;sup>177&lt;/sup>Lu, and &lt;sup>161&lt;/sup>Tb. While there is a lack of F-block PET imaging radionuclides, the in vivo PET generator pair &lt;sup>140&lt;/sup>Nd/&lt;sup>140&lt;/sup>Pr can act as a theranostic imaging counterpart to the F-block therapeutic radionuclides. In this study, we explored the production and separation of high purity &lt;sup>140&lt;/sup>Nd via the &lt;sup>141&lt;/sup>Pr(p,2n)&lt;sup>140&lt;/sup>Nd reaction route. Monoisotopic &lt;sup>141&lt;/sup>Pr targets irradiated with 20 MeV protons for 10 min with 10 µA beam current yielded 21.45 ± 0.82 MBq (580 ± 22 µCi) of &lt;sup>140&lt;/sup>Nd. A two-step separation method was developed for the purification of &lt;sup>140&lt;/sup>Nd from</pubmed_abstract><journal>Scientific reports</journal><pubmed_title>Production and radiochemistry of the in vivo PET generator &amp;lt;sup&amp;gt;140&amp;lt;/sup&amp;gt;Nd/&amp;lt;sup&amp;gt;140&amp;lt;/sup&amp;gt;Pr as an imaging surrogate for F-block therapeutic radionuclides.</pubmed_title><pmcid>PMC12504599</pmcid><funding_grant_id>DESC0020197</funding_grant_id><funding_grant_id>P30CA013148</funding_grant_id><pubmed_authors>Houson HA</pubmed_authors><pubmed_authors>Samuel SL</pubmed_authors><pubmed_authors>Godara ML</pubmed_authors><pubmed_authors>Cingoranelli SJ</pubmed_authors><pubmed_authors>Lapi SE</pubmed_authors><pubmed_authors>Tekin V</pubmed_authors><pubmed_authors>Saini S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Production and radiochemistry of the in vivo PET generator &amp;lt;sup&amp;gt;140&amp;lt;/sup&amp;gt;Nd/&amp;lt;sup&amp;gt;140&amp;lt;/sup&amp;gt;Pr as an imaging surrogate for F-block therapeutic radionuclides.</name><description>Theranostics, a combined approach of diagnostics and therapeutics, often employs F-block therapeutic radionuclides including &lt;sup>225&lt;/sup>Ac, &lt;sup>177&lt;/sup>Lu, and &lt;sup>161&lt;/sup>Tb. While there is a lack of F-block PET imaging radionuclides, the in vivo PET generator pair &lt;sup>140&lt;/sup>Nd/&lt;sup>140&lt;/sup>Pr can act as a theranostic imaging counterpart to the F-block therapeutic radionuclides. In this study, we explored the production and separation of high purity &lt;sup>140&lt;/sup>Nd via the &lt;sup>141&lt;/sup>Pr(p,2n)&lt;sup>140&lt;/sup>Nd reaction route. Monoisotopic &lt;sup>141&lt;/sup>Pr targets irradiated with 20 MeV protons for 10 min with 10 µA beam current yielded 21.45 ± 0.82 MBq (580 ± 22 µCi) of &lt;sup>140&lt;/sup>Nd. A two-step separation method was developed for the purification of &lt;sup>140&lt;/sup>Nd from</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Oct</publication><modification>2026-06-04T05:59:35.549Z</modification><creation>2026-05-06T03:07:53.065Z</creation></dates><accession>S-EPMC12504599</accession><cross_references><pubmed>41057481</pubmed><doi>10.1038/s41598-025-18929-4</doi></cross_references></HashMap>